Pfizer Inc. (New York; www.pfizer.com) and Array BioPharma Inc. (Boulder, CO; www.arraybiopharma.com) have entered into a definitive merger agreement under which Pfizer will acquire Array, a commercial stage biopharmaceutical company focused on the discovery, development and commercialization of targeted small…
Growth in the pharmaceutical and biotechnology industry continues at a dynamic pace. A large number of new diagnostic and therapeutic formulations are exiting from the development pipeline. 49 drugs which were placed on the German market in 2014 are based…
Efficient formulation development leads to up to 60 % time and cost savings Modular or integrated solutions are available Qualified service partners provide own expertise Efficient systems for automated formulation development save valuable research time, and they can also reduce…